欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/1327/001
药品名称Rhinolast 140 micrograms per Spray, Nasal Spray
活性成分
    • Azelastine hydrochloride 0.1 g
剂型Nasal spray, solution
上市许可持有人Mylan IRE Healthcare Limited Unit 35/36, Grange Parade Baldoyle Industrial Estate Dublin 13 Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Malta (MT)
      Rhinolast 140 microgrms nasal spray
许可日期2024/04/02
最近更新日期2024/11/15
药物ATC编码
    • R01AC03 azelastine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Full Dossier Art 8.3(i) Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase